The median age of disease onset was 28 years (22-43) in AChR-Abs MG patients, 38 years (24-48) in MuSK-Abs MG subjects, and 30 years (21-45) in triple-seronegative individuals (p = 0.947). This evidence concerns the gene MUSK and myasthenia gravis.